Abstract

Glass polyalkenoate cements (GPCs) have potential as bio-adhesives due to their ease of application, appropriate mechanical properties, radiopacity and chemical adhesion to bone. Aluminium (Al)-free GPCs have been discussed in the literature, but have proven difficult to balance injectability with mechanical integrity. For example, zinc-based, Al-free GPCs reported compressive strengths of 63 MPa, but set in under 2 min. Here, the authors design injectable GPCs (IGPCs) based on zinc-containing, Al-free silicate compositions containing GeO2, substituted for ZnO at 3% increments through the series. The setting reactions, injectability and mechanical properties of these GPCs were evaluated using both a hand-mix (h) technique, using a spatula for sample preparation and application and an injection (i) technique, using a 16-gauge needle, post mixing, for application. GPCs ability to act as a carrier for bovine serum albumin (BSA) was also evaluated. Germanium (Ge) and BSA containing IGPCs were produced and reported to have working times between 26 and 44 min and setting times between 37 and 55 min; the extended handling properties being as a result of less Ge. The incorporation of BSA into the cement had no effect on the handling and mechanical properties, but the latter were found to have increased compression strength with the addition of Ge from between 27 and 37 MPa after 30 days maturation. Keywords: fracture fixation; distal radius fracture; germanium oxide; polyacrylic acid; injectable glass polyalkenoate cements; bovine serum albumin

Highlights

  • Invasive procedures are receiving increasing attention in the field of orthopedics

  • The first CPCs were based on tetracalcium phosphate (TTCP) and dicalcium phosphate anhydrous (DCPA), which, when combined, transform into HA at neutral pH under isothermic conditions and at physiologic pH [4]

  • A second study was conducted that examined the utility of CPC95 (Biopex; Mitsubishi Material, Saitama, Japan), an injectable CPC consisting of α-tricalcium phosphate (75 weight percent, tetracalcium phosphate (18 wt %), and dicalcium phosphate dihydrate (5 wt %) in treating fractures of the distal radius [7]

Read more

Summary

Introduction

Invasive procedures are receiving increasing attention in the field of orthopedics Such procedures utilize injectable cements, usually, but not always, based on either calcium phosphate or acrylic cement chemistry. These materials can be molded to replicate the bone void and will set in situ. A second study was conducted that examined the utility of CPC95 (Biopex; Mitsubishi Material, Saitama, Japan), an injectable CPC consisting of α-tricalcium phosphate (75 weight percent (wt %), tetracalcium phosphate (18 wt %), and dicalcium phosphate dihydrate (5 wt %) in treating fractures of the distal radius [7]. CPC95 has the potential to be used in treating distal radius fractures due to reports of early mobilization and functional recovery of the treated wrist [7]. CPCs suffer from long setting times and insufficient mechanical properties for load bearing applications in tensile and shear [3]

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call